NAMI
ANAB icon

Nomura Asset Management International’s AnaptysBio ANAB Stock Holding History

Nomura Asset Management International’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.33M Hold
93,732
– – 0.01% 823
2026
Q1 		$5.2M Hold
93,732
– – 0.01% 783
2025
Q4 		$4.54M Buy
+93,732
New +$3.65M 0.01% 817

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Nomura Asset Management International's ANAB Position: Q2 2026 in Review

Nomura Asset Management International held its AnaptysBio (ANAB) position steady in Q2 2026 at 93,732 shares worth $6.33M. The position accounts for 0.01% of the portfolio, ranked #823.

Nomura Asset Management International first reported a position in ANAB in Q4 2025 and has held it in 3 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Nomura Asset Management International held 93,732 shares of AnaptysBio worth $6.33M as of Q2 2026.
  • Nomura Asset Management International left its AnaptysBio share count unchanged in Q2 2026.
  • AnaptysBio made up 0.01% of Nomura Asset Management International's portfolio in Q2 2026, its #823 holding.
  • Nomura Asset Management International first reported a position in AnaptysBio in Q4 2025 and has held it in 3 quarters since.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.